Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
Outlook Therapeutics (NASDAQ: OTLK) reported Q3 EPS of ($0.09). Revenue for the quarter came in at $9 thousand.
For earnings history and earnings-related data on Outlook Therapeutics (OTLK) click here.
Outlook Therapeutics (NASDAQ: OTLK) reported Q3 EPS of ($0.09). Revenue for the quarter came in at $9 thousand.
For earnings history and earnings-related data on Outlook Therapeutics (OTLK) click here.